Literature DB >> 2342482

A tissue-specific enhancer in the rat-calcitonin/CGRP gene is active in both neural and endocrine cell types.

L Stolarsky-Fredman1, S E Leff, E S Klein, E B Crenshaw, J Yeakley, M G Rosenfeld.   

Abstract

The calcitonin gene related peptide (CGRP) gene is a complex transcription unit that is expressed in a highly restricted pattern in both the nervous system, particularly in sensory ganglia and brainstem, and in the thyroid C cells of the endocrine system, with tissue-specific alternative RNA processing events generating transcripts encoding either the hormone, calcitonin, or the neuropeptide, CGRP. This pattern of expression in neural and endocrine tissues raises the question whether similar or distinct genomic elements are responsible for activation in both neural and endocrine cell types. We have identified a complex enhancer element, located more than 1 kilobase 5' of the transcription initiation site of the calcitonin/CGRP gene that functions in cells of neuronal or C cell origin, but not in any other cell type tested. At least two complementary regulatory sequences are required for the function of the cell-specific enhancer.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2342482     DOI: 10.1210/mend-4-3-497

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  10 in total

1.  Localization of cis-acting sequence requirements in the promoter of the latency-associated transcript of herpes simplex virus type 1 required for cell-type-specific activity.

Authors:  A H Batchelor; P O'Hare
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

2.  Commentary: Parallel evolution of Molecular Endocrinology as a journal and a discipline: convergence of interests with the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK/NIH).

Authors:  Ronald Margolis; Philip Smith
Journal:  Mol Endocrinol       Date:  2010-07-21

3.  Human calcitonin gene regulation by helix-loop-helix recognition sequences.

Authors:  D W Ball; D Compton; B D Nelkin; S B Baylin; A de Bustros
Journal:  Nucleic Acids Res       Date:  1992-01-11       Impact factor: 16.971

4.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1990-08-25       Impact factor: 16.971

5.  Distinct signalling pathways mediate the cAMP response element (CRE)-dependent activation of the calcitonin gene-related peptide gene promoter by cAMP and nerve growth factor.

Authors:  K Freeland; Y Z Liu; D S Latchman
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

Review 6.  Thyroid parafollicular cells. An accessible model for the study of serotonergic neurons.

Authors:  A F Russo; M S Clark; P L Durham
Journal:  Mol Neurobiol       Date:  1996-12       Impact factor: 5.590

7.  Repression of the calcitonin gene-related peptide promoter by 5-HT1 receptor activation.

Authors:  P L Durham; R V Sharma; A F Russo
Journal:  J Neurosci       Date:  1997-12-15       Impact factor: 6.167

8.  Retinoic acid repression of cell-specific helix-loop-helix-octamer activation of the calcitonin/calcitonin gene-related peptide enhancer.

Authors:  T M Lanigan; L A Tverberg; A F Russo
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

9.  Thyroid transcription factor 1 is calcium modulated and coordinately regulates genes involved in calcium homeostasis in C cells.

Authors:  K Suzuki; S Lavaroni; A Mori; F Okajima; S Kimura; R Katoh; A Kawaoi; L D Kohn
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

10.  Procalcitonin is expressed in osteoblasts and limits bone resorption through inhibition of macrophage migration during intermittent PTH treatment.

Authors:  Anke Baranowsky; Denise Jahn; Shan Jiang; Timur Yorgan; Peter Ludewig; Jessika Appelt; Kai K Albrecht; Ellen Otto; Paul Knapstein; Antonia Donat; Jack Winneberger; Lana Rosenthal; Paul Köhli; Cordula Erdmann; Melanie Fuchs; Karl-Heinz Frosch; Serafeim Tsitsilonis; Michael Amling; Thorsten Schinke; Johannes Keller
Journal:  Bone Res       Date:  2022-01-27       Impact factor: 13.362

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.